Literature DB >> 26857641

Detection and Analysis of Wnt Pathway Related lncRNAs Expression Profile in Lung Adenocarcinoma.

Jie Chen1, Lijuan Hu2, Jian Chen2, Qinshi Pan2, Hongyan Ding2, Gang Xu2, Peiwu Zhu2, Xiusu Wen2, Keta Huang3, Yumin Wang4.   

Abstract

Studies have shown that the expression profile of Wnt signaling pathway is very important in lung adenocarcinoma (LAD) and some lncRNAs can regulate the expression of key molecules of Wnt pathway. However, Wnt pathway related lncRNAs are not systematically analyzed and detected in lung adenocarcinoma. We used a high-throughput microarray to compare the lncRNA expression profiles in LAD and corresponding normal tissue (NT) samples. Several candidate Wnt pathway related lncRNAs were verified by real-time quantitative reverse transcription polymerase chain reaction (PCR) analysis. We found that 232 Wnt pathway related lncRNAs were obviously expressed (≥2-fold change) in lung adenocarcinoma samples and 13 Wnt pathway related lncRNAs were aberrantly expressed in lung adenocarcinoma compared with matched histologically normal lung tissues by qPCR. Among these, RP11-181G12.2 and RP11-89 K21.1 were the most aberrantly expressed lncRNAs. Our study ascertained the expression of Wnt pathway related lncRNAs in lung adenocarcinoma. The results revealed that many Wnt pathway related lncRNAs were differentially expressed in lung adenocarcinoma tissues, suggesting that they may play a key role in tumor development.

Entities:  

Keywords:  Expression profile; LncRNAs; Lung adenocarcinoma; Wnt pathway

Mesh:

Substances:

Year:  2016        PMID: 26857641     DOI: 10.1007/s12253-016-0046-9

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  15 in total

Review 1.  The Wnt pathway: emerging anticancer strategies.

Authors:  Aman Gupta; Anukriti Verma; Ashutosh K Mishra; Gulshan Wadhwa; Sanjeev K Sharma; Chakresh K Jain
Journal:  Recent Pat Endocr Metab Immune Drug Discov       Date:  2013-05

2.  Long non-coding RNA CCAL regulates colorectal cancer progression by activating Wnt/β-catenin signalling pathway via suppression of activator protein 2α.

Authors:  Yanlei Ma; Yongzhi Yang; Feng Wang; Mary-Pat Moyer; Qing Wei; Peng Zhang; Zhe Yang; Weijie Liu; Huizhen Zhang; Niwei Chen; Hua Wang; Huamin Wang; Huanlong Qin
Journal:  Gut       Date:  2015-05-20       Impact factor: 23.059

3.  Cancer statistics, 2005.

Authors:  Ahmedin Jemal; Taylor Murray; Elizabeth Ward; Alicia Samuels; Ram C Tiwari; Asma Ghafoor; Eric J Feuer; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2005 Jan-Feb       Impact factor: 508.702

4.  LincRNA-p21 enhances the sensitivity of radiotherapy for human colorectal cancer by targeting the Wnt/β-catenin signaling pathway.

Authors:  Guangyu Wang; Zhiwei Li; Qi Zhao; Yuanyuan Zhu; Ci Zhao; Xin Li; Zhigang Ma; Xiaobo Li; Yanqiao Zhang
Journal:  Oncol Rep       Date:  2014-02-24       Impact factor: 3.906

Review 5.  Targeting the Wnt pathway in human cancers: therapeutic targeting with a focus on OMP-54F28.

Authors:  Phuong N Le; Jessica D McDermott; Antonio Jimeno
Journal:  Pharmacol Ther       Date:  2014-08-27       Impact factor: 12.310

6.  Long non-coding RNA UCA1 increases chemoresistance of bladder cancer cells by regulating Wnt signaling.

Authors:  Yu Fan; Bing Shen; Mingyue Tan; Xinyu Mu; Yan Qin; Fang Zhang; Yong Liu
Journal:  FEBS J       Date:  2014-02-20       Impact factor: 5.542

7.  A novel lncRNA, LUADT1, promotes lung adenocarcinoma proliferation via the epigenetic suppression of p27.

Authors:  M Qiu; Y Xu; J Wang; E Zhang; M Sun; Y Zheng; M Li; W Xia; D Feng; R Yin; L Xu
Journal:  Cell Death Dis       Date:  2015-08-20       Impact factor: 8.469

8.  The long non-coding HOTAIR is modulated by cyclic stretch and WNT/β-CATENIN in human aortic valve cells and is a novel repressor of calcification genes.

Authors:  Katrina Carrion; Jeffrey Dyo; Vishal Patel; Roman Sasik; Salah A Mohamed; Gary Hardiman; Vishal Nigam
Journal:  PLoS One       Date:  2014-05-01       Impact factor: 3.240

9.  Wnt signaling pathway pharmacogenetics in non-small cell lung cancer.

Authors:  D J Stewart; D W Chang; Y Ye; M Spitz; C Lu; X Shu; J A Wampfler; R S Marks; Y I Garces; P Yang; X Wu
Journal:  Pharmacogenomics J       Date:  2014-07-01       Impact factor: 3.550

10.  Overexpression of Wnt5a promotes angiogenesis in NSCLC.

Authors:  Lingli Yao; Baocun Sun; Xiulan Zhao; Xueming Zhao; Qiang Gu; Xueyi Dong; Yanjun Zheng; Junying Sun; Runfen Cheng; Hong Qi; Jindan An
Journal:  Biomed Res Int       Date:  2014-06-05       Impact factor: 3.411

View more
  10 in total

1.  MicroRNAs and their target mRNAs as potential biomarkers among smokers and non-smokers with lung adenocarcinoma.

Authors:  Sumaria Malik; Rehan Zafar Paracha; Maryam Khalid; Maryum Nisar; Amnah Siddiqa; Zamir Hussain; Raheel Nawaz; Amjad Ali; Jamil Ahmad
Journal:  IET Syst Biol       Date:  2019-04       Impact factor: 1.615

2.  Identification of skin-related lncRNAs as potential biomarkers that involved in Wnt pathways in keloids.

Authors:  Xiao-Jie Sun; Qiang Wang; Baofeng Guo; Xian-Ying Liu; Bing Wang
Journal:  Oncotarget       Date:  2017-05-23

3.  SNPs in LncRNA genes are associated with non-small cell lung cancer in a Chinese population.

Authors:  Ruoyang Wang; Nannan Feng; Yu Wang; Sumeng Gao; Fangfang Zhang; Ying Qian; Ming Gao; Herbert Yu; Baosen Zhou; Biyun Qian
Journal:  J Clin Lab Anal       Date:  2019-04-13       Impact factor: 2.352

4.  LncRNA HMMR-AS1 promotes proliferation and metastasis of lung adenocarcinoma by regulating MiR-138/sirt6 axis.

Authors:  Yong Cai; Zhaoying Sheng; Yun Chen; Jiying Wang
Journal:  Aging (Albany NY)       Date:  2019-05-25       Impact factor: 5.682

5.  Construction of an immune-related LncRNA signature with prognostic significance for bladder cancer.

Authors:  Wen-Jie Luo; Xi Tian; Wen-Hao Xu; Yuan-Yuan Qu; Wen-Kai Zhu; Jie Wu; Chun-Guang Ma; Hai-Liang Zhang; Ding-Wei Ye; Yi-Ping Zhu
Journal:  J Cell Mol Med       Date:  2021-04-01       Impact factor: 5.310

6.  RNA-binding motif protein 10 represses tumor progression through the Wnt/β- catenin pathway in lung adenocarcinoma.

Authors:  Yingyue Cao; Jianxiong Geng; Xin Wang; Qingwei Meng; Shanqi Xu; Yaoguo Lang; Yongxu Zhou; Lishuang Qi; Zijie Wang; Zixin Wei; Yan Yu; Shi Jin; Bo Pan
Journal:  Int J Biol Sci       Date:  2022-01-01       Impact factor: 6.580

7.  Screening Tumor-Related Genes of Gallbladder Cancer Based on AR-Based Tumor Expression Profile Gene Chip.

Authors:  Jia Guo; Tuotuo Gong; Beina Hui; Xu Zhao; Jing Li
Journal:  Contrast Media Mol Imaging       Date:  2022-09-26       Impact factor: 3.009

8.  Identification of Potential Key Long Non-Coding RNAs and Target Genes Associated with Pneumonia Using Long Non-Coding RNA Sequencing (lncRNA-Seq): A Preliminary Study.

Authors:  Sai Huang; Cong Feng; Li Chen; Zhi Huang; Xuan Zhou; Bei Li; Li-Li Wang; Wei Chen; Fa-Qin Lv; Tan-Shi Li
Journal:  Med Sci Monit       Date:  2016-09-24

9.  SLCO4A1-AS1 promotes cell growth and induces resistance in lung adenocarcinoma by modulating miR-4701-5p/NFE2L1 axis to activate WNT pathway.

Authors:  Yuxuan Wei; Li Wei; Jiwei Li; Zeheng Ma; Quan Zhang; Zhijun Han; Saisai Li
Journal:  Cancer Med       Date:  2020-08-06       Impact factor: 4.452

10.  Construction and analysis of an aberrant lncRNA-miRNA-mRNA network associated with papillary thyroid cancer.

Authors:  Yanxia Jiang; Jiao Wang; Jian Chen; Jiancheng Wang; Jixiong Xu
Journal:  Medicine (Baltimore)       Date:  2020-11-06       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.